IMETAL RESOURCES INC (IMR.CA) Fundamental Analysis & Valuation

TSX-V:IMRCA45250A4063

Current stock price

0.09 CAD
0 (0%)
Last:

This IMR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IMR.CA Profitability Analysis

1.1 Basic Checks

  • IMR had negative earnings in the past year.
  • In the past year IMR has reported a negative cash flow from operations.
  • IMR had negative earnings in each of the past 5 years.
  • IMR had a negative operating cash flow in each of the past 5 years.
IMR.CA Yearly Net Income VS EBIT VS OCF VS FCFIMR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M

1.2 Ratios

  • IMR's Return On Assets of -29.77% is in line compared to the rest of the industry. IMR outperforms 44.65% of its industry peers.
  • Looking at the Return On Equity, with a value of -34.93%, IMR is in line with its industry, outperforming 49.31% of the companies in the same industry.
Industry RankSector Rank
ROA -29.77%
ROE -34.93%
ROIC N/A
ROA(3y)-28.13%
ROA(5y)-30.94%
ROE(3y)-32.31%
ROE(5y)-34.35%
ROIC(3y)N/A
ROIC(5y)N/A
IMR.CA Yearly ROA, ROE, ROICIMR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IMR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMR.CA Yearly Profit, Operating, Gross MarginsIMR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

4

2. IMR.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for IMR has been increased compared to 1 year ago.
  • IMR has more shares outstanding than it did 5 years ago.
  • IMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMR.CA Yearly Shares OutstandingIMR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
IMR.CA Yearly Total Debt VS Total AssetsIMR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • IMR has an Altman-Z score of -7.79. This is a bad value and indicates that IMR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of IMR (-7.79) is worse than 71.19% of its industry peers.
  • There is no outstanding debt for IMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.79
ROIC/WACCN/A
WACCN/A
IMR.CA Yearly LT Debt VS Equity VS FCFIMR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • IMR has a Current Ratio of 0.42. This is a bad value and indicates that IMR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.42, IMR is doing worse than 73.08% of the companies in the same industry.
  • A Quick Ratio of 0.42 indicates that IMR may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.42, IMR is not doing good in the industry: 71.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
IMR.CA Yearly Current Assets VS Current LiabilitesIMR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

0

3. IMR.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.86% over the past year.
EPS 1Y (TTM)55.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. IMR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • IMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMR.CA Price Earnings VS Forward Price EarningsIMR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMR.CA Per share dataIMR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. IMR.CA Dividend Analysis

5.1 Amount

  • No dividends for IMR!.
Industry RankSector Rank
Dividend Yield 0%

IMR.CA Fundamentals: All Metrics, Ratios and Statistics

IMETAL RESOURCES INC

TSX-V:IMR (3/30/2026, 7:00:00 PM)

0.09

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-23
Earnings (Next)04-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.21%
Ins Owner ChangeN/A
Market Cap3.63M
Revenue(TTM)N/A
Net Income(TTM)-2.21M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.77%
ROE -34.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-28.13%
ROA(5y)-30.94%
ROE(3y)-32.31%
ROE(5y)-34.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85830%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z -7.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)35131.1%
Cap/Depr(5y)24285.8%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-202.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.61%
OCF growth 3YN/A
OCF growth 5YN/A

IMETAL RESOURCES INC / IMR.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMETAL RESOURCES INC (IMR.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to IMR.CA.


Can you provide the valuation status for IMETAL RESOURCES INC?

ChartMill assigns a valuation rating of 0 / 10 to IMETAL RESOURCES INC (IMR.CA). This can be considered as Overvalued.


What is the profitability of IMR stock?

IMETAL RESOURCES INC (IMR.CA) has a profitability rating of 1 / 10.


How financially healthy is IMETAL RESOURCES INC?

The financial health rating of IMETAL RESOURCES INC (IMR.CA) is 4 / 10.